Stereotaxis
STXS
81 hedge funds and large institutions have $106M invested in Stereotaxis in 2024 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 5 closing their positions.
400% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 5
112% more call options, than puts
Call options by funds: $240K | Put options by funds: $113K
62% more capital invested
Capital invested by funds: $65.3M → $106M (+$40.4M)
33% more funds holding
Funds holding: 61 → 81 (+20)
11% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 18
3.19% more ownership
Funds ownership: 46.13% → 49.33% (+3.2%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$1.58M |
| 2 |
Millennium Management
New York
|
+$1.55M |
| 3 |
LIM
Lagoda Investment Management
New York
|
+$1.41M |
| 4 |
Goldman Sachs
New York
|
+$827K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$747K |
Top Sellers
STXS Hedge Fund Activity: Q1 2024 in Review
81 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Stereotaxis (STXS) for Q1 2024, worth a combined $106M — up 62% from $65.3M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new STXS positions and 5 closed out — a net gain of 20 holders — while 20 added to existing stakes and 18 trimmed.
The largest buyer was Warberg Asset Management, opening a new position worth an estimated $1.58M. The largest seller was Archon Capital Management, cutting an estimated $1.13M.
- 81 institutional investors held Stereotaxis (STXS) as of Q1 2024, up from 61 in Q4 2023.
- Funds reported $106M of Stereotaxis stock for Q1 2024, up 62% quarter-over-quarter.
- 25 funds opened new Stereotaxis positions in Q1 2024 and 5 closed out, a net change of +20 holders.
- The largest Stereotaxis buyer in Q1 2024 was Warberg Asset Management, an estimated $1.58M added.
- The largest Stereotaxis seller in Q1 2024 was Archon Capital Management, an estimated $1.13M sold.
Based on aggregated 13F filings for Q1 2024.